Teen High-Potency Cannabis Use Linked to Psychosis and Bipolar Disorder Risk
New research published in May 2026 links high-potency cannabis use among teenagers to increased risks of psychosis, bipolar disorder, and suicide. The findings are adding urgency to debates about cannabis legalization policies and youth access.
New data is strengthening the case that high-potency cannabis use among teenagers carries serious mental health risks.
Research highlighted in Psychiatric Times in May 2026 links teen use of high-potency cannabis to increased risks of psychosis, bipolar disorder, and suicide. The findings come as cannabis legalization has expanded across the United States, raising questions about how legal markets affect youth access and use patterns.
The research adds to a growing body of evidence that the brain, still developing through the mid-20s, is particularly vulnerable to the effects of high-THC cannabis products. Earlier studies had found associations between heavy adolescent cannabis use and psychosis, but newer data is sharpening the picture of which young people are most at risk and what types of products pose the greatest danger.
Mental health professionals are calling for clearer public health messaging about the risks, particularly as cannabis products have become more potent and more widely available. Some states have implemented age verification requirements and potency limits, but enforcement varies.
The findings are also relevant to the ongoing debate about psychiatric prescribing. The U.S. Department of Health and Human Services is rolling out a plan to reduce psychiatric overprescribing, but mental health advocates say that reducing medication access without addressing underlying risk factors, including substance use, could leave vulnerable patients without adequate care.
The 988 Suicide and Crisis Lifeline is available 24 hours a day, seven days a week, for anyone in crisis. Call or text 988.
